Jump to navigation
At this symposium, 20 internationally renowned experts from North America, Europe and Asia provided updates and highlighted imminent developments in the diagnosis and treatment of pleuropulmonary disease for the 21st century.
The invitation-only meeting gathers the top scientists to discuss the latest advances in the treatment of lung cancer with targeted therapies.
Join the only international association solely dedicated to lung cancer research and treatment.
The IASLC’s premier journal, emphasizing a multidisciplinary approach including original research (clinical trials and translational or basic research), reviews and opinion pieces.
Visit theWCLC Virtual Library